These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 20880991

  • 1. Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile.
    Bechini A, Boccalini S, Tiscione E, Pesavento G, Mannelli F, Peruzzi M, Rapi S, Mercurio S, Bonanni P.
    Eur J Public Health; 2012 Feb; 22(1):133-9. PubMed ID: 20880991
    [Abstract] [Full Text] [Related]

  • 2. Progress toward measles and rubella elimination in Egypt.
    El Sayed N, Kandeel N, Barakat I, Moussa I, Alexander JP, Naouri B, Reef SE.
    J Infect Dis; 2011 Jul; 204 Suppl 1():S318-24. PubMed ID: 21666180
    [Abstract] [Full Text] [Related]

  • 3. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E, Waight P, Gay N, Ramsay M, Vurdien J, Morgan-Capner P, Hesketh L, Brown D, Tookey P, Peckham C.
    Commun Dis Rep CDR Rev; 1997 Feb 07; 7(2):R26-32. PubMed ID: 9046126
    [Abstract] [Full Text] [Related]

  • 4. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity.
    Kim SS, Han HW, Go U, Chung HW.
    Vaccine; 2004 Dec 02; 23(3):290-7. PubMed ID: 15530670
    [Abstract] [Full Text] [Related]

  • 5. Progress in measles and rubella elimination in Iran.
    Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F.
    Pediatr Infect Dis J; 2007 Dec 02; 26(12):1137-41. PubMed ID: 18043452
    [Abstract] [Full Text] [Related]

  • 6. Toward rubella elimination in Poland: need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts.
    Zimmerman L, Rogalska J, Wannemuehler KA, Haponiuk M, Kosek A, Pauch E, Plonska E, Veltze D, Czarkowski MP, Buddh N, Reef S, Stefanoff P.
    J Infect Dis; 2011 Jul 02; 204 Suppl 1():S389-95. PubMed ID: 21666189
    [Abstract] [Full Text] [Related]

  • 7. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003.
    Hamkar R, Jalilvand S, Mokhtari-Azad T, Jelyani KN, Nategh R.
    Am J Infect Control; 2006 Nov 25; 34(9):588-92. PubMed ID: 17097454
    [Abstract] [Full Text] [Related]

  • 9. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F, Magloire R, Danovaro-Holliday MC, Flannery B, Chamoulliet H, Celestin EP.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [Abstract] [Full Text] [Related]

  • 10. Progress in Italy in control and elimination of measles and congenital rubella.
    Bonanni P, Bechini A, Boccalini S, Peruzzi M, Tiscione E, Boncompagni G, Mannelli F, Salmaso S, Filia A, Ciofi degli Atti M.
    Vaccine; 2007 Apr 20; 25(16):3105-10. PubMed ID: 17306425
    [Abstract] [Full Text] [Related]

  • 11. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience.
    Morice A, Carvajal X, León M, Machado V, Badilla X, Reef S, Lievano F, Depetris A, Castillo-Solórzano C.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S158-63. PubMed ID: 12721908
    [Abstract] [Full Text] [Related]

  • 12. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A, Boxall N, Amirthalingam G, Maddock L, Balasegaram S, Mindlin M.
    Vaccine; 2014 Feb 26; 32(10):1147-52. PubMed ID: 24440207
    [Abstract] [Full Text] [Related]

  • 13. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
    Al-Mazrou YY, Khalil MK, Tischer A, Al-Jeffri MH, Al-Ghamdi YS, Bakhsh MM, Mishkas AA, Elgizouli SA.
    Saudi Med J; 2005 Oct 26; 26(10):1551-4. PubMed ID: 16228054
    [Abstract] [Full Text] [Related]

  • 14. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
    Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P.
    Epidemiol Infect; 2011 Apr 26; 139(4):494-504. PubMed ID: 20587123
    [Abstract] [Full Text] [Related]

  • 15. Approach to verify the status of measles, rubella, and congenital rubella syndrome elimination in Costa Rica.
    Morice A, Avila-Aguero ML, Salas-Peraza D, Soriano A, Castillo-Solórzano C.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S690-7. PubMed ID: 21954268
    [Abstract] [Full Text] [Related]

  • 16. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH, Lee CY, Chih TW, Lee PI, Chang LY, Lin YJ, Hsu CM, Huang LM.
    J Med Virol; 1997 Jan 01; 51(1):32-5. PubMed ID: 8986946
    [Abstract] [Full Text] [Related]

  • 17. A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: vaccine uptake and knowledge and attitudes of students.
    Abd Elaziz KM, Sabbour SM, Dewedar SA.
    Vaccine; 2010 Nov 03; 28(47):7563-8. PubMed ID: 20797454
    [Abstract] [Full Text] [Related]

  • 18. Surveillance and vaccination coverage of measles and rubella in Northern Italy.
    Amendola A, Bubba L, Piralla A, Binda S, Zanetti A, Pariani E, Ranghiero A, Premoli M, Pellegrinelli L, Coppola L, Gramegna M, Baldanti F, Zanetti A.
    Hum Vaccin Immunother; 2015 Nov 03; 11(1):206-13. PubMed ID: 25483537
    [Abstract] [Full Text] [Related]

  • 19. Seroprevalence of measles, mumps and rubella among children in American Samoa, 2011, and progress towards West Pacific Region goals of elimination.
    Mahamud A, Masunu-Faleafaga Y, Walls L, Williams N, Garcia P, Teshale E, Williams R, Dulski T, Bellini WJ, Kutty PK.
    Vaccine; 2013 Aug 12; 31(36):3683-7. PubMed ID: 23770334
    [Abstract] [Full Text] [Related]

  • 20. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination.
    Rainey JJ, Danovaro-Holliday MC, Magloire R, Kananda G, Lee CE, Chamouillet H, Lacapere F, Mung K, Luman ET.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S616-21. PubMed ID: 21954256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.